Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 1,336 other Healthcare companies
Ranked #730 of 1,337 · scores higher than 45% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including MMED · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -5.9% | 1.5% | 26% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 5.4% | 4.2% | 57% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -6.0% | -1.0% | 35% | 20% | |
| Book yieldHigher is better · 1,306 reported | 68.3% | 37.9% | 75% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 730 | 1.9B USD | 45 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 730 | 725M USD | 45 | 19 |
| 730 | 27.5B NZD (≈$16.5B) | 45 | 69 |
| 730 | 118.0B INR (≈$1.4B) | 45 | 68 |
| 730 | 5.3B USD | 45 | 50 |
| 730 | 30.4B INR (≈$365M) | 45 | 39 |
| 743 | 2.8B CNY (≈$394M) | 44 | 39 |
| 743 | 21.6B CNY (≈$3.0B) | 44 | 41 |
| 743 | 11.2B DKK (≈$1.7B) | 44 | 59 |